KENOX PHARMACEUTICALS Trademark

Trademark Overview

On Tuesday, May 31, 2022, a trademark application was filed for KENOX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the KENOX PHARMACEUTICALS trademark a serial number of 97436436. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, October 25, 2024. This trademark is owned by Kenox Pharmaceuticals Inc.. The KENOX PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of pharmaceutical preparations
kenox pharmaceuticals

General Information

Serial Number97436436
Word MarkKENOX PHARMACEUTICALS
Filing DateTuesday, May 31, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, October 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 11, 2023

Trademark Statements

Description of MarkThe mark consists of the word "KENOX" in stylized capital letters, with the "E" represented by three parallel horizontal lines and the "O" represented by three unconnected arcs in the form of a circle, with a series of circular solid dots in a helical array both inside and outside the "O", all of the aforesaid appearing over the word "PHARMACEUTICALS" in smaller stylized capital letters.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesResearch and development services in the field of pharmaceutical preparations

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 7, 2022
Primary Code042
First Use Anywhere DateTuesday, October 1, 2019
First Use In Commerce DateTuesday, October 1, 2019

Trademark Owner History

Party NameKenox Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080
Party NameKenox Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth Plainfield, NJ 07080

Trademark Events

Event DateEvent Description
Tuesday, June 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 3, 2022NEW APPLICATION ENTERED
Wednesday, June 8, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 16, 2023ASSIGNED TO EXAMINER
Thursday, March 16, 2023NON-FINAL ACTION WRITTEN
Thursday, March 16, 2023NON-FINAL ACTION E-MAILED
Thursday, March 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 21, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 11, 2023PUBLISHED FOR OPPOSITION
Friday, January 5, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, July 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, January 5, 2024USE AMENDMENT FILED
Friday, January 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 22, 2024NON-FINAL ACTION E-MAILED
Friday, January 26, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 22, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, February 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 2, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, May 2, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, October 1, 2024EXAMINERS AMENDMENT E-MAILED
Friday, October 25, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 25, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 1, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 1, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, October 1, 2024SU-EXAMINER'S AMENDMENT WRITTEN

Related Keywords

pharmaceuticals kenox pharmaceutical preparations field services development research